The global anticholinergic drugs market benefits from the expanding geriatric population, as age-related health conditions can increase the need for respiratory, urinary, and neurological treatments. However, prescribing decisions must consider potential adverse effects and cumulative anticholinergic burden, particularly among older adults.
The anticholinergic drugs market was valued at US$...
English
Arabic
French
Spanish
Portuguese
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek